Reskin Medical
ActiveSummary
Reskin Medical has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €371k and a net result of €137k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 55% of 218 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
83
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability93▲+22
Solvency77▼-23
Growth62=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 2.09 against 5.51 in 2024; short-term debt: 48% and cash: 33.7% of total assets), and 48% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
52%
Return on assets
19.3%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
58 d early
2024
3 d early
2023
1 d early
2022
4 d early
2021
29 d late
2020
17 d early
2019
4 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
€914k▲ 15.7%
2019 · €790k
2018: €697k
2019: €790k
2018 → 2020
EBIT margin
28.8%▲ 1.0pp
2019 · 27.8%
2018: 34.7%
2019: 27.8%
2018 → 2020
Net result
€137k▲ 1,087%
2024 · €12k
2018: €228k
2019: €207k
2020: €257k
2021: €230k
2022: €115k
2023: €-226k
2024: €12k
2018 → 2025
Working capital
€371k▼ 23.2%
2024 · €483k
2018: €455k
2019: €292k
2020: €323k
2021: €552k
2022: €676k
2023: €461k
2024: €483k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€583k-€697k▲ 19.7%€472k▼ 32.4%€483k▲ 2.5%€371k▼ 23.3%
Operating result€206k-€116k▼ 43.8%€-224k€12k€138k▲ 1,061%
Net result€230k-€115k▼ 50.2%€-226k€12k€137k▲ 1,087%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 1,061% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €712k
Equity
€371k ▼ 23.3%
Debt
€342k ▲ 219%
Debt's share of the balance-sheet total rises from 18.1% to 48.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€139k▲
2024 · €23k
Cash flow
€138k▲
2024 · €22k
Current ratio
2.09▼
2024 · 5.51
Quick ratio
1.88▼
2024 · 3.93
Debt to equity
0.92▲
2024 · 0.22
ROE
37.1%▲
2024 · 2.4%
ROA
19.3%▲
2024 · 2.0%
Interest coverage
132.79▲
2024 · 51.86
Debt ≤ 1 year
€342k▲
2024 · €107k
Staff costs
€187▼
2024 · €287
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet
Code20242025
Assets
Total assets20/58€590k€712k▲
Fixed assets21/28€383-
Tangible fixed assets22/27€383-
Plant, machinery and equipment23€383-
Furniture and vehicles24€0-
Current assets29/58€590k€712k▲
Stocks and contracts in progress3€169k€69k▼
Stocks30/36€169k€69k▼
Amounts receivable within one year40/41€160k€403k▲
Trade receivables40€146k€189k▲
Other amounts receivable41€14k€214k▲
Cash at bank and in hand54/58€261k€240k▼
Equity and liabilities
Total equity and liabilities10/49€590k€712k▲
Equity10/15€483k€371k▼
Contributions10/11€329k€329k=
Capital10€329k€329k=
Issued capital100€329k€329k=
Reserves13€26k€33k▲
Non-distributable reserves130/1€26k€33k▲
Legal reserve130€26k€33k▲
Profit (loss) carried forward14€128k€9k▼
Amounts payable17/49€107k€342k▲
Amounts payable within one year42/48€107k€342k▲
Trade debts44€107k€86k▼
Suppliers440/4€107k€86k▼
Taxes, remuneration and social security45-€6k
Taxes450/3-€6k
Other amounts payable47/48-€250k
Accrued charges and deferred income492/3-€56
Income statement
Code20242025
Remuneration, social security and pensions62€287€187▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11k€383▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€-102k
Other operating charges640/8€4k€4k▼
Gross operating margin9900€27k€41k▲
Operating profit (loss)9901€12k€138k▲
Financial income75/76B€459€114▼
Recurring financial income75€459€114▼
Financial charges65/66B€436€1k▲
Recurring financial charges65€436€1k▲
Profit (loss) for the period before taxes9903€12k€137k▲
Income taxes67/77€361-
Profit (loss) for the period9904€12k€137k▲
Profit (loss) for the period to be appropriated9905€12k€137k▲
Appropriation of the result
Profit (loss) to be appropriated9906€135k€266k▲
Profit (loss) brought forward from the previous period14P€124k€128k▲
Transfer to equity691/2€7k€7k▲
To the legal reserve6920€7k€7k▲
Profit to be distributed694/7-€250k
Return on contributions (dividend)694-€250k
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
28-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Back to profitnet €12k
Net result €12k after one loss-making year.
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Weakest financial yearnet €-226k ▼297%
Net result drops to €-226k, the lowest in the series; recovery starts the following year.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
31-12
Financial
Equity above €500kEq €583k ▲65.4%
4 profitable years in a row build equity to €583k.
14-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Highest result since 2018net €257k ▲23.7%
Operating result €264k, net result €257k, both a record.
31-12
Financial
Equity above €200kEq €352k ▲268%
3 profitable years in a row build equity to €352k.
04-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 4 days late
Show earlier events
2019
03-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
11-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
8 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tessenderlo-Ham · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Industrieweg (H) 1143980 Tessenderlo-HamGround area
1.2 ha
Building footprint
5,068 m²
Volume, LiDAR
29,084 m³
Parcel 71363C0176/00F000, Flanders · tallest building 33.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Reskin Medical
since 20102.194.225.419
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71363C0176/00F000 | Flanders | 1.2 ha | 1 · 5,068 m² | 33.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500878F5137G00457
Similar companies · same sector, comparable size
Bosmans Dentaal Labo
BE 0764.759.876
Sint-Katelijne-Waver · Eq €370,268
BRYS - CALLEWAERT
BE 0448.892.541
Sint-Niklaas · Eq €371,875
TELEMECO
BE 0447.551.070
Leuven · Eq €367,404
DENTAL ART
BE 0883.114.130
Zottegem · Eq €364,608
OOGA
BE 0827.624.487
Dendermonde · Eq €364,591
Of 1,249 companies in sector 32500 we hold annual accounts for 694. 512 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded17-09-2010
Fiscal year end31-12
Activities, NACEBEL 2025
32500Manufacture of medical and dental instruments and supplies
46180Agents specialised in the wholesale of other particular products
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.